Table 1.
Characteristics | n | % |
---|---|---|
Enrolled | 78 | 100 |
Sex | ||
Male | 43 | 55 |
Female | 35 | 45 |
Age, years median (range) | 64 (30–78) | |
ECOG performance status | ||
0 | 22 | 28 |
1 | 51 | 65 |
2 | 5 | 6 |
Primary site | ||
Cecum | 7 | 9 |
Ascending colon | 4 | 5 |
Hepatic flexure of the large intestine | 3 | 4 |
Transverse colon | 4 | 5 |
Splenic flexure of the large intestine | 4 | 5 |
Colon descending | 3 | 4 |
Sigmoid | 17 | 22 |
Rectosigmoid junction | 8 | 10 |
Rectum | 28 | 36 |
Primary tumor location | ||
Right colon | 17 | 22 |
Left colon | 61 | 78 |
Primary tumor histological subtype | ||
Adenocarcinoma | 73 | 94 |
Mucinous adenocarcinoma | 4 | 5 |
Signet ring cell carcinoma | 1 | 1 |
Histological differentiation: | ||
Well | 10 | 13 |
Moderate | 51 | 65 |
Poorly | 6 | 8 |
Unknown | 11 | 14 |
pT category | ||
pT1 | 1 | 1 |
pT2 | 7 | 9 |
pT3 | 48 | 62 |
pT4 | 17 | 22 |
Not operated on | 5 | 6 |
pN category | ||
pN0 | 18 | 23 |
pN1 | 28 | 36 |
pN2 | 27 | 35 |
not operated on | 5 | 6 |
Site of metastasis | ||
Liver | 49 | 63 |
Lung | 19 | 24 |
Lymph node | 18 | 23 |
Peritoneum | 16 | 21 |
KRAS mutation status | ||
Wild-type | 36 | 46 |
Mutant | 40 | 51 |
BRAF mutation status | ||
Wild-type | 61 | 78 |
Mutant | 6 | 7 |
NRAS mutation status | ||
Wild-type | 72 | 92 |
Mutant | 1 | 1 |
Abbreviation: ECOG Eastern Cooperative Oncology Group; pT: size or direct extent of the primary tumor given by histopathologic examination of a surgical specimen according to TNM staging system; pN: degree of spread to regional lymph nodes given by histopathologic examination of a surgical specimen.